Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1990 1
1995 1
2004 1
2005 3
2006 1
2007 2
2009 1
2010 2
2011 1
2012 4
2013 2
2014 1
2015 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Three months of rifapentine and isoniazid for latent tuberculosis infection.
Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR Jr, Chaisson RE; TB Trials Consortium PREVENT TB Study Team. Sterling TR, et al. N Engl J Med. 2011 Dec 8;365(23):2155-66. doi: 10.1056/NEJMoa1104875. N Engl J Med. 2011. PMID: 22150035 Free article. Clinical Trial.
The conformation of lipid-free human apolipoprotein A-I in solution.
Pollard RD, Fulp B, Samuel MP, Sorci-Thomas MG, Thomas MJ. Pollard RD, et al. Among authors: Samuel MP. Biochemistry. 2013 Dec 31;52(52):9470-81. doi: 10.1021/bi401080k. Epub 2013 Dec 17. Biochemistry. 2013. PMID: 24308268 Free PMC article.
Fatty acid metabolites in rapidly proliferating breast cancer.
O'Flaherty JT, Wooten RE, Samuel MP, Thomas MJ, Levine EA, Case LD, Akman SA, Edwards IJ. O'Flaherty JT, et al. Among authors: Samuel MP. PLoS One. 2013 May 2;8(5):e63076. doi: 10.1371/journal.pone.0063076. Print 2013. PLoS One. 2013. PMID: 23658799 Free PMC article.
Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.
Bliven-Sizemore EE, Sterling TR, Shang N, Benator D, Schwartzman K, Reves R, Drobeniuc J, Bock N, Villarino ME; TB Trials Consortium. Bliven-Sizemore EE, et al. Int J Tuberc Lung Dis. 2015 Sep;19(9):1039-44, i-v. doi: 10.5588/ijtld.14.0829. Int J Tuberc Lung Dis. 2015. PMID: 26260821 Free PMC article. Clinical Trial.
Cholesteryl esters associated with acyl-CoA:cholesterol acyltransferase predict coronary artery disease in patients with symptoms of acute coronary syndrome.
Miller CD, Thomas MJ, Hiestand B, Samuel MP, Wilson MD, Sawyer J, Rudel LL. Miller CD, et al. Among authors: Samuel MP. Acad Emerg Med. 2012 Jun;19(6):673-82. doi: 10.1111/j.1553-2712.2012.01378.x. Acad Emerg Med. 2012. PMID: 22687182 Free PMC article.
20 results
Jump to page
Feedback